Novartis Access: Medicines to treat chronic diseases in lower-income countries

Novartis recently announced the launch of the Novartis Access Portfolio, a first-of-its-kind portfolio approach in healthcare industry, aiming to increase availability and affordability of 15 medicines against cardiovascular diseases, diabetes, respiratory illnesses and breast cancer in low and middle income countries.

Videos from Client

Content from this campaign

Awards & Rankings
« Prix Hermès de l'innovation » for Novartis Access
Novartis Access is the 2016 winner of the "Prix Hermès de l'innovation" in the category “Improvement of the human condition”. Jürgen Brokatzky-Geiger, Head of Novartis Access, collected the award during the official ceremony in Paris on June 14.
Health & Healthcare
Perfecting Access Through Embedded Sustainability, Pooling Resources and Consolidating Expertise
Anthony Gitau is Country Head of Novartis Access and Familia Nawiri in Kenya. In his current role, Anthony Gitau is in charge of implementing and scaling up the two social business programs of Novartis in Kenya. These are meant to empower people living at the base of the pyramid to take control of their health and to give them access to quality affordable healthcare services and products. Anthony tells his story about his passion for working on affordable access programs on EFPIA Blog.
Health & Healthcare
Africa Has a New Health Challenge, and We Need a Plan to Fight It
While the headlines might focus on Ebola or yellow fever, Africa is slowly winning the fight against infectious diseases. They will remain a challenge for decades to come, but the real threat of the future is expected to come from elsewhere: non-communicable diseases (NCDs) like diabetes, cardiovascular disease and cancer. We must find creative new ways to tackle these health challenges, which will call for us to pool resources and expertise from all those involved in the delivery of healthcare.
Health & Healthcare
Novartis and Red Cross Partner to Tackle Chronic Diseases in Refugee Populations
Syrian refugees in Lebanon suffering from chronic diseases face difficulties accessing diagnosis, medicines and ongoing care. The International Committee of the Red Cross (ICRC) and Novartis are partnering to improve care and treatment for the most vulnerable population in Lebanon. The objective is to establish a blueprint for improving diagnosis, treatment and follow-up for refugees, as well as members of their Lebanese host families, who suffer from chronic diseases.
Sustainable Finance & Socially Responsible Investment
First Novartis Access Treatments Delivered to Kenya
We are pleased to announce that the first Novartis Access shipment has just been delivered to Kenya. This shipment includes medicines against cardiovascular diseases, diabetes, respiratory conditions and breast cancer. The medicines are currently stored in the MEDS warehouse (Mission for Essential Drugs and Supplies) in Nairobi.
Health & Healthcare
Expanding Access to Affordable Treatments Against Chronic Diseases
On May 25, Novartis Access held its second stakeholder dialogue in conjunction with the 2016 World Health Assembly to share first learnings from the Kenya launch, and to continue the discussion on how to address the burden of noncommunicable diseases (NCDs) in lower-income countries. This event is part of the company’s public commitment to transparency and open dialogue with stakeholders as Novartis Access is rolled out.
Health & Healthcare
Kenya First Country to Launch ‘Novartis Access’, Expanding Affordable Treatment Options Against Chronic Diseases
Today, Novartis announced the launch of Novartis Access in Kenya, the first country to benefit from a portfolio of 15 affordable medicines to treat cardiovascular diseases, diabetes, respiratory illnesses, and breast cancer. The Novartis portfolio is being offered to the Kenyan government, non-governmental organizations and other public-sector healthcare providers for USD 1 per treatment, per month.
Health & Healthcare
Novartis Launches ‘Novartis Access’, a Portfolio of Affordable Medicines to Treat Chronic Diseases in Lower-income Countries
Novartis today announced the launch of Novartis Access, a portfolio of 15 medicines to treat chronic diseases in low- and low-middle-income countries. The portfolio addresses cardiovascular diseases, diabetes, respiratory illnesses, and breast cancer and will be offered to governments, non-governmental organizations (NGOs) and other public-sector healthcare providers for USD 1 per treatment, per month.

More from Novartis

The Novartis Malaria Initiative

For over a decade, the Novartis Malaria Initiative has been a pioneer in the fight against malaria. Focused on access, treatment, R&D and capacity...